Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STYX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPP2R2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF180 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RPL23A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928269 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERPINB5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
RHBDL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101929694 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF204P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC35G3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRWD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEPROT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on